Your browser doesn't support javascript.
loading
Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients.
Milcent, Benoit; Josseaume, Nathalie; Riller, Quentin; Giglioli, Ilenia; Rabia, Emilia; Deligne, Claire; Latouche, Jean-Baptiste; Hamieh, Mohamad; Couture, Alexandre; Toutirais, Olivier; Lone, Yu-Chun; Jeger-Madiot, Raphaël; Graff-Dubois, Stéphanie; Amorim, Sandy; Loiseau, Pascale; Toubert, Antoine; Brice, Pauline; Thieblemont, Catherine; Teillaud, Jean-Luc; Sibéril, Sophie.
Affiliation
  • Milcent B; Sorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Inserm UMRS 1138, "Cancer, Immune Control and Escape" Laboratory, Centre de Recherche des Cordeliers, Paris, France.
  • Josseaume N; Sorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Inserm UMRS 1138, "Cancer, Immune Control and Escape" Laboratory, Centre de Recherche des Cordeliers, Paris, France.
  • Riller Q; Sorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Inserm UMRS 1138, "Cancer, Immune Control and Escape" Laboratory, Centre de Recherche des Cordeliers, Paris, France.
  • Giglioli I; Sorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Inserm UMRS 1138, "Cancer, Immune Control and Escape" Laboratory, Centre de Recherche des Cordeliers, Paris, France.
  • Rabia E; Sorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Inserm UMRS 1138, "Cancer, Immune Control and Escape" Laboratory, Centre de Recherche des Cordeliers, Paris, France.
  • Deligne C; Sorbonne Université, Sorbonne Paris Cité, Université Paris Descartes, Université Paris Diderot, Inserm UMRS 1138, "Cancer, Immune Control and Escape" Laboratory, Centre de Recherche des Cordeliers, Paris, France.
  • Latouche JB; Inserm U1245, Institute for Research and Innovation in Biomedicine (IRIB), Normandie University, Rouen University Hospital, Rouen, France.
  • Hamieh M; Inserm U1245, Institute for Research and Innovation in Biomedicine (IRIB), Normandie University, Rouen University Hospital, Rouen, France.
  • Couture A; Inserm U1245, Institute for Research and Innovation in Biomedicine (IRIB), Normandie University, Rouen University Hospital, Rouen, France.
  • Toutirais O; Unicaen, Inserm 1237, Physiopathology and Imaging of Neurological Disorders, Normandie University, Caen, France.
  • Lone YC; French Blood Service (Etablissement Français du Sang, EFS), Caen, France.
  • Jeger-Madiot R; Inserm U1014, Hôpital Paul Brousse, Villejuif, France.
  • Graff-Dubois S; Inserm U1135, CNRS ERL8255, Center for Immunology and Microbial Infection, Paris, France.
  • Amorim S; Inserm U1135, CNRS ERL8255, Center for Immunology and Microbial Infection, Paris, France.
  • Loiseau P; APHP, Saint-Louis Hospital, Hemato-oncology, Diderot University, Sorbonne Paris Cité, Paris, France.
  • Toubert A; Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint-Louis, Paris, France.
  • Brice P; Inserm UMR-S 1160, Paris, France.
  • Thieblemont C; Institut Universitaire d'Hématologie, Université Paris Diderot-Paris 7, Paris, France.
  • Teillaud JL; Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint-Louis, Paris, France.
  • Sibéril S; Inserm UMR-S 1160, Paris, France.
Cancer Immunol Immunother ; 68(10): 1561-1572, 2019 Oct.
Article in En | MEDLINE | ID: mdl-31494742
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / Antigens, CD20 / Lymphoma Limits: Animals / Female / Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2019 Document type: Article Affiliation country: Francia Country of publication: Alemania
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: CD4-Positive T-Lymphocytes / Antigens, CD20 / Lymphoma Limits: Animals / Female / Humans Language: En Journal: Cancer Immunol Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2019 Document type: Article Affiliation country: Francia Country of publication: Alemania